Disclosure: All authors state that they have no conflicts of interest and have nothing to disclose.
Gender Dimorphism and Lack of Day/Night Variation or Effects of Energy Deprivation on Undercarboxylated Osteocalcin Levels in Humans
Article first published online: 13 JUN 2013
Copyright © 2013 The Obesity Society
Volume 21, Issue 12, pages E527–E532, December 2013
How to Cite
Foo, J.-P., Aronis, K. N., Chamberland, J. P., Thakkar, B., Hamnvik, O.-P., Brinkoetter, M., Zaichenko, L. and Mantzoros, C. S. (2013), Gender Dimorphism and Lack of Day/Night Variation or Effects of Energy Deprivation on Undercarboxylated Osteocalcin Levels in Humans. Obesity, 21: E527–E532. doi: 10.1002/oby.20453
Funding agencies: The Mantzoros Laboratory is supported by the National Institute of Diabetes and Digestive and Kidney Diseases grants 58785, 79929 and 81913. The Mantzoros Laboratory is also supported by Award Number 1I01CX000422-01A1 from the Clinical Science Research and Development Service of the VA Office of Research and Development. Amylin Pharmaceuticals, Inc. supplied metreleptin for this study and approved the design of the study but had no role in the study design; conduct of the study; collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript. The project described was also supported by Grant Number UL1 RR025758- Harvard Clinical and Translational Science Center, from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.
- Issue published online: 3 DEC 2013
- Article first published online: 13 JUN 2013
- Accepted manuscript online: 20 MAR 2013 02:21AM EST
- Manuscript Accepted: 28 FEB 2013
- Manuscript Received: 24 SEP 2012
- 10Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J Clin Endocrinol Metab 2011;96:E1982-E1989., Sellmeyer DE, Schwartz AV.